Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Enhanced efficacy of combination of gemcitabine and phosphatidylserine-targeted nanovesicles against pancreatic cancer

Enhanced efficacy of combination of gemcitabine and phosphatidylserine-targeted nanovesicles against pancreatic cancer

US Patent 12478658 · Granted Nov 25, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for monitoring a surge in a fluid device and refrigeration system2020